The healthcare market has entered a period of high-stakes execution in 2026. Many companies have been adding mid- to late-stage assets as they seek to minimize clinical risk and move rapidly toward commercialization. At the same time, significant regulatory and operational headwinds threaten to derail the sectorβs momentum. This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
Execution in Focus: Tracking Key Healthcare and Biopharma Trends in 2026
About the Authors
Sara Mallatt, Director of Healthcare Research
Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelorβs degree in journalism and a masterβs in industrial engineering. She works from her home in Missoula, Montana.
Sean Carmichael
Sean is a Senior Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.
Explore more
Security, Privacy & Trust in the Age of AI
In this report, discover the foundational questions and principles that firms should be requiring of AI providers as they prioritize scaling trustworthy AI infrastructure.
Top AI Use Cases for Investor Relations
The AI era has ushered in a new reality for investor relations. Discover how the leading IR teams are harnessing AI to unify peer tracking, sentiment analysis, and real-time market monitoring into a single intelligence layer.
Top AI Use Cases for Venture Capital Firms
In this report, discover how venture capital teams are leveraging AI for decision-grade intelligence that distills signal from noise in a crowded environment.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities,β¨and lead with clarity and confidence.